SCHEMBL2893771

SCHEMBL2893771

Cc1c(C(=O)O)sc2ccc(F)cc12

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 2/20 0.58
BCKDK O14874 1/20 0.54
TBXAS1 P24557 2/20 0.49
RXFP1 Q9HBX9 2/20 0.47
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PRNP P04156 1/20 0.44
MCL1 Q07820 2/20 0.43
BCL2L1 Q07817 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.42
MKNK2 Q9HBH9 2/20 0.41
CMA1 P23946 3/20 0.41
DHODH Q02127 2/20 0.40
F10 P00742 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1443637 0.88 GPR35 (0.53) GPR35BCKDKTBXAS1RXFP1PKM
SCHEMBL6963675 0.87 CMA1 (0.46) GPR35BCKDKTBXAS1RXFP1NPSR1
SCHEMBL2895162 0.87 BCKDK (0.67) GPR35BCKDKTBXAS1RXFP1PKM
SCHEMBL10007005 0.84 GPR35 (0.49) GPR35BCKDKTBXAS1RXFP1PKM
SCHEMBL2895952 0.83 GPR35 (0.62) GPR35BCKDKTBXAS1RXFP1PKM
SCHEMBL4342850 0.83 CMA1 (0.41) GPR35BCKDKTBXAS1RXFP1PRNP
SCHEMBL31126911 0.83 TRPM8 (0.42) GPR35BCKDKTBXAS1RXFP1PRNP
SCHEMBL9757077 0.81 GPR35 (0.65) GPR35BCKDKTBXAS1RXFP1PKM
SCHEMBL1066852 0.80 GPR35 (0.58) GPR35BCKDKTBXAS1RXFP1PKM
SCHEMBL2896475 0.80 GPR35 (0.58) GPR35TBXAS1RXFP1PKMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732477-B2 N-(1-azabicyclo[2.2.2]oct-3-yl)-heteroaryl carboxamides; alpha 7-nicotinic acetylcholine receptors (nAChR) agonists; improving perception, concentration, learning and memory; neuropathic pain; acute and chronic pain BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-08 US disclosed